The group is now elucidating the role of inflammation and immune responses in the hepatic microenvironment of tumors during the genesis and progression of hepatocellular carcinoma.
That is the question!
Investigating how HCV contributes to cancer development.
Assessing factors influencing liver cancer outcomes.
Examining immune cells’ roles within tumor environments.
Finding new drug targets for disease treatment.